Literature DB >> 1392080

Periodic changes in phosphorylation of the Xenopus cdc25 phosphatase regulate its activity.

T Izumi1, D H Walker, J L Maller.   

Abstract

The cdc25 tyrosine phosphatase is known to activate cdc2 kinase in the G2/M transition by dephosphorylation of tyrosine 15. To determine how entry into M-phase in eukaryotic cells is controlled, we have investigated the regulation of the cdc25 protein in Xenopus eggs and oocytes. Two closely related Xenopus cdc25 genes have been cloned and sequenced and specific antibodies generated. The cdc25 phosphatase activity oscillates in both meiotic and mitotic cell cycles, being low in interphase and high in M-phase. Increased activity of cdc25 at M-phase is accompanied by increased phosphorylation that retards electrophoretic mobility in gels from 76 to 92 kDa. Treatment of cdc25 with either phosphatase 1 or phosphatase 2A removes phosphate from cdc25, reverses the mobility shift, and decreases its ability to activate cdc2 kinase. Furthermore, the addition of okadaic acid to egg extracts arrested in S-phase by aphidicolin causes phosphorylation and activation of the cdc25 protein before cyclin B/cdc2 kinase activation. These results demonstrate that the activity of the cdc25 phosphatase at the G2/M transition is directly regulated through changes in its phosphorylation state.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1392080      PMCID: PMC275649          DOI: 10.1091/mbc.3.8.927

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  50 in total

Review 1.  Coupling M phase and S phase: controls maintaining the dependence of mitosis on chromosome replication.

Authors:  T Enoch; P Nurse
Journal:  Cell       Date:  1991-06-14       Impact factor: 41.582

2.  Two interdependent basic domains in nucleoplasmin nuclear targeting sequence: identification of a class of bipartite nuclear targeting sequence.

Authors:  J Robbins; S M Dilworth; R A Laskey; C Dingwall
Journal:  Cell       Date:  1991-02-08       Impact factor: 41.582

Review 3.  Universal control mechanism regulating onset of M-phase.

Authors:  P Nurse
Journal:  Nature       Date:  1990-04-05       Impact factor: 49.962

4.  Protein tyrosine phosphatase activity of an essential virulence determinant in Yersinia.

Authors:  K L Guan; J E Dixon
Journal:  Science       Date:  1990-08-03       Impact factor: 47.728

5.  Human homolog of fission yeast cdc25 mitotic inducer is predominantly expressed in G2.

Authors:  K Sadhu; S I Reed; H Richardson; P Russell
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

6.  One of the protein phosphatase 1 isoenzymes in Drosophila is essential for mitosis.

Authors:  J M Axton; V Dombrádi; P T Cohen; D M Glover
Journal:  Cell       Date:  1990-10-05       Impact factor: 41.582

7.  Completion of DNA replication is monitored by a feedback system that controls the initiation of mitosis in vitro: studies in Xenopus.

Authors:  M Dasso; J W Newport
Journal:  Cell       Date:  1990-06-01       Impact factor: 41.582

8.  cdc25 is a specific tyrosine phosphatase that directly activates p34cdc2.

Authors:  J Gautier; M J Solomon; R N Booher; J F Bazan; M W Kirschner
Journal:  Cell       Date:  1991-10-04       Impact factor: 41.582

9.  p55CDC25 is a nuclear protein required for the initiation of mitosis in human cells.

Authors:  J B Millar; J Blevitt; L Gerace; K Sadhu; C Featherstone; P Russell
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

10.  Cdc2 H1 kinase is negatively regulated by a type 2A phosphatase in the Xenopus early embryonic cell cycle: evidence from the effects of okadaic acid.

Authors:  M A Félix; P Cohen; E Karsenti
Journal:  EMBO J       Date:  1990-03       Impact factor: 11.598

View more
  96 in total

1.  A novel p34(cdc2)-binding and activating protein that is necessary and sufficient to trigger G(2)/M progression in Xenopus oocytes.

Authors:  I Ferby; M Blazquez; A Palmer; R Eritja; A R Nebreda
Journal:  Genes Dev       Date:  1999-08-15       Impact factor: 11.361

2.  Overproduction of human Myt1 kinase induces a G2 cell cycle delay by interfering with the intracellular trafficking of Cdc2-cyclin B1 complexes.

Authors:  F Liu; C Rothblum-Oviatt; C E Ryan; H Piwnica-Worms
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

3.  Absence of Wee1 ensures the meiotic cell cycle in Xenopus oocytes.

Authors:  N Nakajo; S Yoshitome; J Iwashita; M Iida; K Uto; S Ueno; K Okamoto; N Sagata
Journal:  Genes Dev       Date:  2000-02-01       Impact factor: 11.361

Review 4.  Cell cycle checkpoints and their inactivation in human cancer.

Authors:  M Molinari
Journal:  Cell Prolif       Date:  2000-10       Impact factor: 6.831

5.  Cytoplasmic localization of human cdc25C during interphase requires an intact 14-3-3 binding site.

Authors:  S N Dalal; C M Schweitzer; J Gan; J A DeCaprio
Journal:  Mol Cell Biol       Date:  1999-06       Impact factor: 4.272

6.  Binding of 14-3-3 proteins and nuclear export control the intracellular localization of the mitotic inducer Cdc25.

Authors:  A Kumagai; W G Dunphy
Journal:  Genes Dev       Date:  1999-05-01       Impact factor: 11.361

7.  Absence of apparent phenotype in mice lacking Cdc25C protein phosphatase.

Authors:  M S Chen; J Hurov; L S White; T Woodford-Thomas; H Piwnica-Worms
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

8.  Nif1, a novel mitotic inhibitor in Schizosaccharomyces pombe.

Authors:  L Wu; P Russell
Journal:  EMBO J       Date:  1997-03-17       Impact factor: 11.598

9.  Regulation of Cdc2/cyclin B activation in Xenopus egg extracts via inhibitory phosphorylation of Cdc25C phosphatase by Ca(2+)/calmodulin-dependent protein [corrected] kinase II.

Authors:  James R A Hutchins; Dina Dikovskaya; Paul R Clarke
Journal:  Mol Biol Cell       Date:  2003-07-11       Impact factor: 4.138

10.  PP1 control of M phase entry exerted through 14-3-3-regulated Cdc25 dephosphorylation.

Authors:  Seth S Margolis; Susan Walsh; Douglas C Weiser; Minoru Yoshida; Shirish Shenolikar; Sally Kornbluth
Journal:  EMBO J       Date:  2003-11-03       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.